ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global IPV Vaccine Market Research Report 2025
Published Date: January 2025
|
Report Code: QYRE-Auto-20K10970
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global IPV Vaccine Market Research Report 2022
BUY CHAPTERS

Global IPV Vaccine Market Research Report 2025

Code: QYRE-Auto-20K10970
Report
January 2025
Pages:73
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
GlaxoSmithKline PLC
Sanofi
Serum Institute of India Pvt. Ltd
AJ Vaccines
PT Bio Farma

IPV Vaccine Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

IPV Vaccine Market

IPV Vaccine Market

The global market for IPV Vaccine was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for IPV Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding IPV Vaccine.
The IPV Vaccine market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global IPV Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the IPV Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of IPV Vaccine Market Report

Report Metric Details
Report Name IPV Vaccine Market
CAGR 5%
Segment by Type
  • Mahoney
  • MEF1
  • Saukett
Segment by Application
  • Private Distribution Channel
  • Public Distribution Channel
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company GlaxoSmithKline Plc, Sanofi S.A, Serum Institute of India Pvt. Ltd., PT Bio Farma, AJ Vaccines
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of IPV Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of IPV Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the IPV Vaccine Market report?

Ans: The main players in the IPV Vaccine Market are GlaxoSmithKline Plc, Sanofi S.A, Serum Institute of India Pvt. Ltd., PT Bio Farma, AJ Vaccines

What are the Application segmentation covered in the IPV Vaccine Market report?

Ans: The Applications covered in the IPV Vaccine Market report are Private Distribution Channel, Public Distribution Channel

What are the Type segmentation covered in the IPV Vaccine Market report?

Ans: The Types covered in the IPV Vaccine Market report are Mahoney, MEF1, Saukett

Recommended Reports

Vaccine Types

Vaccine Additives & Processing

Vaccine Packaging & Logistics

1 IPV Vaccine Market Overview
1.1 Product Definition
1.2 IPV Vaccine by Type
1.2.1 Global IPV Vaccine Market Value Comparison by Type (2024 VS 2031)
1.2.2 Mahoney
1.2.3 MEF1
1.2.4 Saukett
1.3 IPV Vaccine by Application
1.3.1 Global IPV Vaccine Market Value by Application (2024 VS 2031)
1.3.2 Private Distribution Channel
1.3.3 Public Distribution Channel
1.4 Global IPV Vaccine Market Size Estimates and Forecasts
1.4.1 Global IPV Vaccine Revenue 2020-2031
1.4.2 Global IPV Vaccine Sales 2020-2031
1.4.3 Global IPV Vaccine Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 IPV Vaccine Market Competition by Manufacturers
2.1 Global IPV Vaccine Sales Market Share by Manufacturers (2020-2025)
2.2 Global IPV Vaccine Revenue Market Share by Manufacturers (2020-2025)
2.3 Global IPV Vaccine Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of IPV Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of IPV Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of IPV Vaccine, Product Type & Application
2.7 Global Key Manufacturers of IPV Vaccine, Date of Enter into This Industry
2.8 Global IPV Vaccine Market Competitive Situation and Trends
2.8.1 Global IPV Vaccine Market Concentration Rate
2.8.2 The Global 5 and 10 Largest IPV Vaccine Players Market Share by Revenue
2.8.3 Global IPV Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global IPV Vaccine Market Scenario by Region
3.1 Global IPV Vaccine Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global IPV Vaccine Sales by Region: 2020-2031
3.2.1 Global IPV Vaccine Sales by Region: 2020-2025
3.2.2 Global IPV Vaccine Sales by Region: 2026-2031
3.3 Global IPV Vaccine Revenue by Region: 2020-2031
3.3.1 Global IPV Vaccine Revenue by Region: 2020-2025
3.3.2 Global IPV Vaccine Revenue by Region: 2026-2031
3.4 North America IPV Vaccine Market Facts & Figures by Country
3.4.1 North America IPV Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America IPV Vaccine Sales by Country (2020-2031)
3.4.3 North America IPV Vaccine Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe IPV Vaccine Market Facts & Figures by Country
3.5.1 Europe IPV Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe IPV Vaccine Sales by Country (2020-2031)
3.5.3 Europe IPV Vaccine Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific IPV Vaccine Market Facts & Figures by Region
3.6.1 Asia Pacific IPV Vaccine Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific IPV Vaccine Sales by Region (2020-2031)
3.6.3 Asia Pacific IPV Vaccine Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America IPV Vaccine Market Facts & Figures by Country
3.7.1 Latin America IPV Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America IPV Vaccine Sales by Country (2020-2031)
3.7.3 Latin America IPV Vaccine Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa IPV Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa IPV Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa IPV Vaccine Sales by Country (2020-2031)
3.8.3 Middle East and Africa IPV Vaccine Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global IPV Vaccine Sales by Type (2020-2031)
4.1.1 Global IPV Vaccine Sales by Type (2020-2025)
4.1.2 Global IPV Vaccine Sales by Type (2026-2031)
4.1.3 Global IPV Vaccine Sales Market Share by Type (2020-2031)
4.2 Global IPV Vaccine Revenue by Type (2020-2031)
4.2.1 Global IPV Vaccine Revenue by Type (2020-2025)
4.2.2 Global IPV Vaccine Revenue by Type (2026-2031)
4.2.3 Global IPV Vaccine Revenue Market Share by Type (2020-2031)
4.3 Global IPV Vaccine Price by Type (2020-2031)
5 Segment by Application
5.1 Global IPV Vaccine Sales by Application (2020-2031)
5.1.1 Global IPV Vaccine Sales by Application (2020-2025)
5.1.2 Global IPV Vaccine Sales by Application (2026-2031)
5.1.3 Global IPV Vaccine Sales Market Share by Application (2020-2031)
5.2 Global IPV Vaccine Revenue by Application (2020-2031)
5.2.1 Global IPV Vaccine Revenue by Application (2020-2025)
5.2.2 Global IPV Vaccine Revenue by Application (2026-2031)
5.2.3 Global IPV Vaccine Revenue Market Share by Application (2020-2031)
5.3 Global IPV Vaccine Price by Application (2020-2031)
6 Key Companies Profiled
6.1 GlaxoSmithKline Plc
6.1.1 GlaxoSmithKline Plc Company Information
6.1.2 GlaxoSmithKline Plc Description and Business Overview
6.1.3 GlaxoSmithKline Plc IPV Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.1.4 GlaxoSmithKline Plc IPV Vaccine Product Portfolio
6.1.5 GlaxoSmithKline Plc Recent Developments/Updates
6.2 Sanofi S.A
6.2.1 Sanofi S.A Company Information
6.2.2 Sanofi S.A Description and Business Overview
6.2.3 Sanofi S.A IPV Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Sanofi S.A IPV Vaccine Product Portfolio
6.2.5 Sanofi S.A Recent Developments/Updates
6.3 Serum Institute of India Pvt. Ltd.
6.3.1 Serum Institute of India Pvt. Ltd. Company Information
6.3.2 Serum Institute of India Pvt. Ltd. Description and Business Overview
6.3.3 Serum Institute of India Pvt. Ltd. IPV Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Serum Institute of India Pvt. Ltd. IPV Vaccine Product Portfolio
6.3.5 Serum Institute of India Pvt. Ltd. Recent Developments/Updates
6.4 PT Bio Farma
6.4.1 PT Bio Farma Company Information
6.4.2 PT Bio Farma Description and Business Overview
6.4.3 PT Bio Farma IPV Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.4.4 PT Bio Farma IPV Vaccine Product Portfolio
6.4.5 PT Bio Farma Recent Developments/Updates
6.5 AJ Vaccines
6.5.1 AJ Vaccines Company Information
6.5.2 AJ Vaccines Description and Business Overview
6.5.3 AJ Vaccines IPV Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.5.4 AJ Vaccines IPV Vaccine Product Portfolio
6.5.5 AJ Vaccines Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 IPV Vaccine Industry Chain Analysis
7.2 IPV Vaccine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 IPV Vaccine Production Mode & Process Analysis
7.4 IPV Vaccine Sales and Marketing
7.4.1 IPV Vaccine Sales Channels
7.4.2 IPV Vaccine Distributors
7.5 IPV Vaccine Customer Analysis
8 IPV Vaccine Market Dynamics
8.1 IPV Vaccine Industry Trends
8.2 IPV Vaccine Market Drivers
8.3 IPV Vaccine Market Challenges
8.4 IPV Vaccine Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
GlaxoSmithKline PLC
Sanofi
Serum Institute of India Pvt. Ltd
AJ Vaccines
PT Bio Farma
List of Tables
 Table 1. Global IPV Vaccine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global IPV Vaccine Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global IPV Vaccine Market Competitive Situation by Manufacturers in 2024
 Table 4. Global IPV Vaccine Sales (Units) of Key Manufacturers (2020-2025)
 Table 5. Global IPV Vaccine Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global IPV Vaccine Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global IPV Vaccine Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market IPV Vaccine Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of IPV Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of IPV Vaccine, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of IPV Vaccine, Product Type & Application
 Table 12. Global Key Manufacturers of IPV Vaccine, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global IPV Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in IPV Vaccine as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global IPV Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global IPV Vaccine Sales by Region (2020-2025) & (Units)
 Table 18. Global IPV Vaccine Sales Market Share by Region (2020-2025)
 Table 19. Global IPV Vaccine Sales by Region (2026-2031) & (Units)
 Table 20. Global IPV Vaccine Sales Market Share by Region (2026-2031)
 Table 21. Global IPV Vaccine Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global IPV Vaccine Revenue Market Share by Region (2020-2025)
 Table 23. Global IPV Vaccine Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global IPV Vaccine Revenue Market Share by Region (2026-2031)
 Table 25. North America IPV Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America IPV Vaccine Sales by Country (2020-2025) & (Units)
 Table 27. North America IPV Vaccine Sales by Country (2026-2031) & (Units)
 Table 28. North America IPV Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America IPV Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe IPV Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe IPV Vaccine Sales by Country (2020-2025) & (Units)
 Table 32. Europe IPV Vaccine Sales by Country (2026-2031) & (Units)
 Table 33. Europe IPV Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe IPV Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific IPV Vaccine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific IPV Vaccine Sales by Region (2020-2025) & (Units)
 Table 37. Asia Pacific IPV Vaccine Sales by Region (2026-2031) & (Units)
 Table 38. Asia Pacific IPV Vaccine Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific IPV Vaccine Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America IPV Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America IPV Vaccine Sales by Country (2020-2025) & (Units)
 Table 42. Latin America IPV Vaccine Sales by Country (2026-2031) & (Units)
 Table 43. Latin America IPV Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America IPV Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa IPV Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa IPV Vaccine Sales by Country (2020-2025) & (Units)
 Table 47. Middle East and Africa IPV Vaccine Sales by Country (2026-2031) & (Units)
 Table 48. Middle East and Africa IPV Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa IPV Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global IPV Vaccine Sales (Units) by Type (2020-2025)
 Table 51. Global IPV Vaccine Sales (Units) by Type (2026-2031)
 Table 52. Global IPV Vaccine Sales Market Share by Type (2020-2025)
 Table 53. Global IPV Vaccine Sales Market Share by Type (2026-2031)
 Table 54. Global IPV Vaccine Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global IPV Vaccine Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global IPV Vaccine Revenue Market Share by Type (2020-2025)
 Table 57. Global IPV Vaccine Revenue Market Share by Type (2026-2031)
 Table 58. Global IPV Vaccine Price (US$/Unit) by Type (2020-2025)
 Table 59. Global IPV Vaccine Price (US$/Unit) by Type (2026-2031)
 Table 60. Global IPV Vaccine Sales (Units) by Application (2020-2025)
 Table 61. Global IPV Vaccine Sales (Units) by Application (2026-2031)
 Table 62. Global IPV Vaccine Sales Market Share by Application (2020-2025)
 Table 63. Global IPV Vaccine Sales Market Share by Application (2026-2031)
 Table 64. Global IPV Vaccine Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global IPV Vaccine Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global IPV Vaccine Revenue Market Share by Application (2020-2025)
 Table 67. Global IPV Vaccine Revenue Market Share by Application (2026-2031)
 Table 68. Global IPV Vaccine Price (US$/Unit) by Application (2020-2025)
 Table 69. Global IPV Vaccine Price (US$/Unit) by Application (2026-2031)
 Table 70. GlaxoSmithKline Plc Company Information
 Table 71. GlaxoSmithKline Plc Description and Business Overview
 Table 72. GlaxoSmithKline Plc IPV Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. GlaxoSmithKline Plc IPV Vaccine Product
 Table 74. GlaxoSmithKline Plc Recent Developments/Updates
 Table 75. Sanofi S.A Company Information
 Table 76. Sanofi S.A Description and Business Overview
 Table 77. Sanofi S.A IPV Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Sanofi S.A IPV Vaccine Product
 Table 79. Sanofi S.A Recent Developments/Updates
 Table 80. Serum Institute of India Pvt. Ltd. Company Information
 Table 81. Serum Institute of India Pvt. Ltd. Description and Business Overview
 Table 82. Serum Institute of India Pvt. Ltd. IPV Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Serum Institute of India Pvt. Ltd. IPV Vaccine Product
 Table 84. Serum Institute of India Pvt. Ltd. Recent Developments/Updates
 Table 85. PT Bio Farma Company Information
 Table 86. PT Bio Farma Description and Business Overview
 Table 87. PT Bio Farma IPV Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. PT Bio Farma IPV Vaccine Product
 Table 89. PT Bio Farma Recent Developments/Updates
 Table 90. AJ Vaccines Company Information
 Table 91. AJ Vaccines Description and Business Overview
 Table 92. AJ Vaccines IPV Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. AJ Vaccines IPV Vaccine Product
 Table 94. AJ Vaccines Recent Developments/Updates
 Table 95. Key Raw Materials Lists
 Table 96. Raw Materials Key Suppliers Lists
 Table 97. IPV Vaccine Distributors List
 Table 98. IPV Vaccine Customers List
 Table 99. IPV Vaccine Market Trends
 Table 100. IPV Vaccine Market Drivers
 Table 101. IPV Vaccine Market Challenges
 Table 102. IPV Vaccine Market Restraints
 Table 103. Research Programs/Design for This Report
 Table 104. Key Data Information from Secondary Sources
 Table 105. Key Data Information from Primary Sources
 Table 106. Authors List of This Report


List of Figures
 Figure 1. Product Picture of IPV Vaccine
 Figure 2. Global IPV Vaccine Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global IPV Vaccine Market Share by Type: 2024 & 2031
 Figure 4. Mahoney Product Picture
 Figure 5. MEF1 Product Picture
 Figure 6. Saukett Product Picture
 Figure 7. Global IPV Vaccine Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global IPV Vaccine Market Share by Application: 2024 & 2031
 Figure 9. Private Distribution Channel
 Figure 10. Public Distribution Channel
 Figure 11. Global IPV Vaccine Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global IPV Vaccine Market Size (2020-2031) & (US$ Million)
 Figure 13. Global IPV Vaccine Sales (2020-2031) & (Units)
 Figure 14. Global IPV Vaccine Average Price (US$/Unit) & (2020-2031)
 Figure 15. IPV Vaccine Report Years Considered
 Figure 16. IPV Vaccine Sales Share by Manufacturers in 2024
 Figure 17. Global IPV Vaccine Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest IPV Vaccine Players: Market Share by Revenue in IPV Vaccine in 2024
 Figure 19. IPV Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global IPV Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America IPV Vaccine Sales Market Share by Country (2020-2031)
 Figure 22. North America IPV Vaccine Revenue Market Share by Country (2020-2031)
 Figure 23. United States IPV Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada IPV Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe IPV Vaccine Sales Market Share by Country (2020-2031)
 Figure 26. Europe IPV Vaccine Revenue Market Share by Country (2020-2031)
 Figure 27. Germany IPV Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France IPV Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. IPV Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy IPV Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia IPV Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific IPV Vaccine Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific IPV Vaccine Revenue Market Share by Region (2020-2031)
 Figure 34. China IPV Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan IPV Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea IPV Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India IPV Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia IPV Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan IPV Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Indonesia IPV Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Thailand IPV Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Malaysia IPV Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Latin America IPV Vaccine Sales Market Share by Country (2020-2031)
 Figure 44. Latin America IPV Vaccine Revenue Market Share by Country (2020-2031)
 Figure 45. Mexico IPV Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Brazil IPV Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Argentina IPV Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Middle East and Africa IPV Vaccine Sales Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa IPV Vaccine Revenue Market Share by Country (2020-2031)
 Figure 50. Turkey IPV Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia IPV Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. UAE IPV Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Global Sales Market Share of IPV Vaccine by Type (2020-2031)
 Figure 54. Global Revenue Market Share of IPV Vaccine by Type (2020-2031)
 Figure 55. Global IPV Vaccine Price (US$/Unit) by Type (2020-2031)
 Figure 56. Global Sales Market Share of IPV Vaccine by Application (2020-2031)
 Figure 57. Global Revenue Market Share of IPV Vaccine by Application (2020-2031)
 Figure 58. Global IPV Vaccine Price (US$/Unit) by Application (2020-2031)
 Figure 59. IPV Vaccine Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano String

SIMILAR REPORTS

Global Viral Vaccines Market Research Report 2025
Global Inactivated Polio Virus Vaccine Market Research Report 2025
Global Livestock Vaccine Market Research Report 2025
Global Attenuated Vaccine Market Research Report 2025
Vaccines Delivery Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
mRNA Vaccines for Infectious Diseases Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Vaccine Digital Data Logger Market Insights Forecast to 2030
Global GP Vaccination Market Research Report 2025
Viral Vaccine Media Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Vaccine Delivery Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Influenza A Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Inactivated Influenza Vaccine Market
Global Trivalent Flu Vaccine Market Insights Forecast to 2030
Global Vaccine Cooler Market Research Report 2025
Viral Vector and Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Vaccine Ampoules Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Trivalent Inactivated Influenza Vaccine Market Research Report 2025
Preventable Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Vaccines Packaging Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Vaccination Cart Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions